G Holló - Expert Opin. Drug Saf., 2007 - informahealthcare.com In the last decade topically applied prostaglandin F2α analogues (bimatoprost,
latanoprost, travoprost and unoprostone) have become widely used as a means to
reduce elevated intraocular pressure in patients with glaucoma and ocular ... Cited by 19 - Related articles - BL Direct - All 7 versions
I Grierson, M Jonsson, K Cracknell - Japanese journal of ophthalmology, 2004 - Springer Abstract Latanoprost is a prostaglandin analogue with well-established efficacy
in the treatment of open-angle glaucoma and ocular hypertension. Once-daily
administration of this drug for up to 5 years is generally well tolerated ... Cited by 9 - Related articles - All 3 versions
KPB Cracknell, I Grierson, P Hogg - Ophthalmology, 2007 - Elsevier Iridectomy specimens from LIID cases were collected from patients undergoing
trabeculectomy, whereas before surgery they had been on topical latanoprost and
there was clear evidence of iris color change from the treating ... Cited by 7 - Related articles - All 24 versions
RJ Noecker - Therapeutics and Clinical Risk Management, 2006 - pubmedcentral.nih.gov In the last decade, numerous novel ocular hypotensive agents have been
introduced for the control of intraocular pressure (IOP). Clinicians now have
more options than ever in the selection of medical therapy for the ... Cited by 3 - Related articles - BL Direct - All 6 versions
L Rossetti, S Gandolfi, C Traverso, P … - Journal of Glaucoma, 2006 - journals.lww.com Journal of Glaucoma. Wolters Kluwer Health | Lippincott
Williams & Wilkins. All Issues. ... Cited by 2 - Related articles - All 16 versions
ВП Еричев, ЛВ Якубова - Глаукома - glaucomajournal.ru В ольшинство медикаментоз- ных средств,
использовав- шихся до последнего вре- мени в
лечении первичной открыто- угольной ... Cited by 1 - Related articles - View as HTML
SK Law - Current opinion in ophthalmology, 2009 - journals.lww.com Recent findings: Although efficacies of medications within a therapeutic class
are similar and significant differences are generally not observed in clinical
trials, response to medication often varies among individual patients in a ... Related articles - All 3 versions
KH Chien, DW Lu, JT Chen - Cutaneous and Ocular Toxicology, 2009 - informahealthcare.com Prostaglandin analogues have been reported to cause periorbital pigmentation. We
report a case of open-angle glaucoma in which extensive facial skin pigmentation
was noticed as an adverse effect of the use of latanoprost (Xalatan; Pfizer ... Related articles - All 3 versions
